top of page
Thechnology & Pre-clinical Recearch
Hero Image Shortcut-01.jpg


ShortCut™ Catheter 


Unmet Needs in Current TAVI World



TAVI Valve-01.jpg
TAVI Valve-02.jpg

Degenerated valves that require reintervention present a risk of coronary obstruction and coronary access impairment

TAVI in native valves present a risk of coronary impairment in a select group of patients

ShortCut™ Catheter

First dedicated transcatheter leaflet splitting device

ShortCut Catheter
ShortCut Catheter
ShortCut Catheter

Intended to enable coronary access and prevent coronary obstruction during TAVI

Complete control over positioning and leaflet splitting location

Designed for safe, simple splitting of single or double leaflets, with short procedural times

The ShortCut™ Procedure

Pi-Cardia ShortCut Procedure
Play Video

CAUTION Investigational device. Limited by Federal law to Investigational Use. The ShortCut™ device is to be used exclusively for clinical investigations.

Pi-Cardia owns multiple issued patents and pending patent applications in multiple jurisdictions around the world that cover or relate to various aspects of the technology embedded in the ShortCut™.  US Patent 11,690,637

bottom of page